167 related articles for article (PubMed ID: 1124104)
1. Suppression of delayed hypersensitivity in schistosome-infected patients by niridazole.
Webster LT; Butterworth AE; Mahmoud AA; Mngola EN; Warren KS
N Engl J Med; 1975 May; 292(22):1144-7. PubMed ID: 1124104
[TBL] [Abstract][Full Text] [Related]
2. Delayed hypersensitivity to specific antigen and hetrologous PPD antigen in patients infected with Schistosoma mansoni and/or Schistosoma haematobium.
el-Kalouby AH; Amer R; Abdel-Wahab MF; el-Raziky EH
Egypt J Bilharz; 1979; 6(1-2):43-9. PubMed ID: 263096
[TBL] [Abstract][Full Text] [Related]
3. Cell-mediated immune assay in children with Schistosoma haematobium infection and the effect of niridazole therapy.
Abdel-Salam E; Higashi GI; Kamal KA; Ishaac S
Trans R Soc Trop Med Hyg; 1981; 75(2):207-14. PubMed ID: 7303134
[TBL] [Abstract][Full Text] [Related]
4. Niridazole, a potent long-acting suppressant of cellular hypersensitivity. III. Minimal suppression of antibody responses.
Pelley RP; Pelley RJ; Stavitsky AB; Mahmoud AA; Warren KS
J Immunol; 1975 Dec; 115(6):1477-82. PubMed ID: 1184961
[TBL] [Abstract][Full Text] [Related]
5. The acquisition and loss of antigen-specific cellular immune responsiveness in acute and chronic schistosomiasis in man.
Ottesen EA; Hiatt RA; Cheever AW; Sotomayor ZR; Neva FA
Clin Exp Immunol; 1978 Jul; 33(1):37-47. PubMed ID: 709912
[TBL] [Abstract][Full Text] [Related]
6. Niridazole. II. A potent long-acting suppressant of cellular hypersensitivity.
Mahmoud AA; Mandel A; Warren K; Webster LT
J Immunol; 1975 Jan; 114(1 Pt 2):279-83. PubMed ID: 1090648
[TBL] [Abstract][Full Text] [Related]
7. [Effect of niridazole on Schistosoma mansoni. Clinical and experimental results].
Tribouley J; Tribouley-Duret J; Pautrizel AN; Pautrizel R
Bull Soc Pathol Exot Filiales; 1972; 65(4):550-63. PubMed ID: 4679130
[No Abstract] [Full Text] [Related]
8. Schistosomiasis.
Mahmoud AA
N Engl J Med; 1977 Dec; 297(24):1329-31. PubMed ID: 917088
[No Abstract] [Full Text] [Related]
9. Studies on the mechanism of suppression of delayed hypersensitivity by the antischistosomal compund niridazole.
Daniels JC; Warren KS; David JR
J Immunol; 1975 Nov; 115(5):1414-21. PubMed ID: 51891
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of niridazole and hycanthone in schistosomiasis mansoni endemic areas.
Katz N
J Toxicol Environ Health; 1975 Nov; 1(2):203-9. PubMed ID: 1107578
[TBL] [Abstract][Full Text] [Related]
11. A trial of the suppression of infection of Bulinus snails during ambilhar (niridazole) therapy of bilharziasis.
El-Gindy MS; Mousa AH; Roushdy MZ
Egypt J Bilharz; 1974; 1(2):261-77. PubMed ID: 4471064
[No Abstract] [Full Text] [Related]
12. [Oltipraz as brief treatment of schistosomiasis (comparison with niridazole) (author's transl)].
Pieron R; Lesobre B; Mafart Y; Lancastre F
Med Trop (Mars); 1980; 40(3):301-11. PubMed ID: 6995790
[TBL] [Abstract][Full Text] [Related]
13. Assessment of immediate and delayed hypersensitivity skin tests with Schistosoma mansoni adult worm antigen in a rural Egyptian population.
Higashi GI; El-Asfahani AM; El-Bolkainy MN; Chu EW; Raafat M
Trop Geogr Med; 1980 Sep; 32(3):245-50. PubMed ID: 7210159
[TBL] [Abstract][Full Text] [Related]
14. Effect of niridazole on the lipid pattern of the parasite and host tissues in experimental schistosomiasis mansoni.
Khayyal MT; Mousa AH; Saleh S; Abo-HASHISH MA; Metwally AA
Egypt J Bilharz; 1978; 4(1):89-96. PubMed ID: 648459
[TBL] [Abstract][Full Text] [Related]
15. Praziquantel compared to niridazole in schistosomiasis intercalatum therapy.
Feldmeier H; Zwingenberger K; Steiner A; Dietrich M
Tropenmed Parasitol; 1981 Mar; 32(1):39-42. PubMed ID: 7233551
[TBL] [Abstract][Full Text] [Related]
16. [Control for 1 year following niridazole treatment of Schistosoma haematobium and S. mansoni bilharziasis].
Pieron R; Lesobre B; Mafart Y; Lancastre F; Hercend T
Ann Soc Belg Med Trop; 1980 Mar; 60(1):27-32. PubMed ID: 7469544
[No Abstract] [Full Text] [Related]
17. Sustained release of niridazole from silicone rubber implants for the treatment of Schistosoma mansoni infections.
Olanoff LS; Mahmound AA; Anderson JM
Am J Trop Med Hyg; 1980 Jan; 29(1):71-3. PubMed ID: 7352630
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the host response in human schistosomiasis. IV. Parasite antigen induces release of histamine that inhibits lymphocyte responsiveness in vitro.
Hofstetter M; Fasano MB; Ottesen EA
J Immunol; 1983 Mar; 130(3):1376-80. PubMed ID: 6185579
[TBL] [Abstract][Full Text] [Related]
19. The use of a molluscicide in conjunction with chemotherapy to control Schistosoma haematobium at the Barombi Lake foci in Cameroon. II. Urinary examination methods, the use of niridazole to attack the parasite in man, and the effect on transmission from man to snail.
Duke BO; Moore PJ
Tropenmed Parasitol; 1976 Dec; 27(4):489-504. PubMed ID: 1006804
[TBL] [Abstract][Full Text] [Related]
20. New aspects of the chemothrapy of bilharziasis with Ambilhar (Niridazole).
Fontanilles F
Egypt J Bilharz; 1974; 1(1):29-34. PubMed ID: 4619884
[No Abstract] [Full Text] [Related]
[Next] [New Search]
